- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
According to our latest study, the global Neuromodulation Devices and Implantable Infusion Pumps market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson's disease, Epilepsy, etc.
This report is a detailed and comprehensive analysis for global Neuromodulation Devices and Implantable Infusion Pumps market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2018-2029
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2018-2029
Global Neuromodulation Devices and Implantable Infusion Pumps market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Unit), and average selling prices (USD/Unit), 2018-2029
Global Neuromodulation Devices and Implantable Infusion Pumps market shares of main players, shipments in revenue ($ Million), sales quantity (Unit), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Neuromodulation Devices and Implantable Infusion Pumps
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Neuromodulation Devices and Implantable Infusion Pumps market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical and Nevro Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Neuromodulation Devices and Implantable Infusion Pumps market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial Magnetic Stimulation
Transcutaneous Electrical Stimulation
Other
Market segment by Application
Parkinson's Disease
Epilepsy
Pain
Other
Major players covered
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with price, sales, revenue and global market share of Neuromodulation Devices and Implantable Infusion Pumps from 2018 to 2023.
Chapter 3, the Neuromodulation Devices and Implantable Infusion Pumps competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neuromodulation Devices and Implantable Infusion Pumps breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neuromodulation Devices and Implantable Infusion Pumps.
Chapter 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Neuromodulation Devices and Implantable Infusion Pumps
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Vagal Nerve Stimulation
1.3.6 Gastric Stimulation
1.3.7 Transcranial Magnetic Stimulation
1.3.8 Transcutaneous Electrical Stimulation
1.3.9 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Parkinson's Disease
1.4.3 Epilepsy
1.4.4 Pain
1.4.5 Other
1.5 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size & Forecast
1.5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2018-2029)
1.5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Medtronic Recent Developments/Updates
2.2 Boston Scientific Corporation
2.2.1 Boston Scientific Corporation Details
2.2.2 Boston Scientific Corporation Major Business
2.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boston Scientific Corporation Recent Developments/Updates
2.3 St. Jude Medical
2.3.1 St. Jude Medical Details
2.3.2 St. Jude Medical Major Business
2.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 St. Jude Medical Recent Developments/Updates
2.4 Synapse Biomedical
2.4.1 Synapse Biomedical Details
2.4.2 Synapse Biomedical Major Business
2.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Synapse Biomedical Recent Developments/Updates
2.5 Nevro Corporation
2.5.1 Nevro Corporation Details
2.5.2 Nevro Corporation Major Business
2.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nevro Corporation Recent Developments/Updates
2.6 Neuropace
2.6.1 Neuropace Details
2.6.2 Neuropace Major Business
2.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Neuropace Recent Developments/Updates
2.7 Cyberonics
2.7.1 Cyberonics Details
2.7.2 Cyberonics Major Business
2.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Cyberonics Recent Developments/Updates
2.8 Autonomic Technologies
2.8.1 Autonomic Technologies Details
2.8.2 Autonomic Technologies Major Business
2.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Autonomic Technologies Recent Developments/Updates
2.9 Avery Biomedical
2.9.1 Avery Biomedical Details
2.9.2 Avery Biomedical Major Business
2.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Avery Biomedical Recent Developments/Updates
2.10 Greatbatch Medical
2.10.1 Greatbatch Medical Details
2.10.2 Greatbatch Medical Major Business
2.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
2.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Greatbatch Medical Recent Developments/Updates
3 Competitive Environment: Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2018-2023)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2018-2023)
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2022
3.4.2 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2022
3.5 Neuromodulation Devices and Implantable Infusion Pumps Market: Overall Company Footprint Analysis
3.5.1 Neuromodulation Devices and Implantable Infusion Pumps Market: Region Footprint
3.5.2 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
3.5.3 Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2018-2029)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2018-2029)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2018-2029)
4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029)
4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029)
4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029)
4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029)
4.6 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2029)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2018-2029)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2029)
6.2 Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2018-2029)
6.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2018-2029)
7 North America
7.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2029)
7.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2029)
7.3 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
7.3.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2029)
7.3.2 North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2029)
8.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2029)
8.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
8.3.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2029)
8.3.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region
9.3.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2029)
10.2 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2029)
10.3 South America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
10.3.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2029)
10.3.2 South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country
11.3.1 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
12.3 Neuromodulation Devices and Implantable Infusion Pumps Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Neuromodulation Devices and Implantable Infusion Pumps and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neuromodulation Devices and Implantable Infusion Pumps
13.3 Neuromodulation Devices and Implantable Infusion Pumps Production Process
13.4 Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
14.3 Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 6. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Medtronic Recent Developments/Updates
Table 8. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Boston Scientific Corporation Major Business
Table 10. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 11. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boston Scientific Corporation Recent Developments/Updates
Table 13. St. Jude Medical Basic Information, Manufacturing Base and Competitors
Table 14. St. Jude Medical Major Business
Table 15. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 16. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. St. Jude Medical Recent Developments/Updates
Table 18. Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table 19. Synapse Biomedical Major Business
Table 20. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 21. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Synapse Biomedical Recent Developments/Updates
Table 23. Nevro Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Nevro Corporation Major Business
Table 25. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 26. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nevro Corporation Recent Developments/Updates
Table 28. Neuropace Basic Information, Manufacturing Base and Competitors
Table 29. Neuropace Major Business
Table 30. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 31. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Neuropace Recent Developments/Updates
Table 33. Cyberonics Basic Information, Manufacturing Base and Competitors
Table 34. Cyberonics Major Business
Table 35. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 36. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cyberonics Recent Developments/Updates
Table 38. Autonomic Technologies Basic Information, Manufacturing Base and Competitors
Table 39. Autonomic Technologies Major Business
Table 40. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 41. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Autonomic Technologies Recent Developments/Updates
Table 43. Avery Biomedical Basic Information, Manufacturing Base and Competitors
Table 44. Avery Biomedical Major Business
Table 45. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 46. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Avery Biomedical Recent Developments/Updates
Table 48. Greatbatch Medical Basic Information, Manufacturing Base and Competitors
Table 49. Greatbatch Medical Major Business
Table 50. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product and Services
Table 51. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (Unit), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Greatbatch Medical Recent Developments/Updates
Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Manufacturer (2018-2023) & (Unit)
Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Neuromodulation Devices and Implantable Infusion Pumps, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Neuromodulation Devices and Implantable Infusion Pumps Production Site of Key Manufacturer
Table 58. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Type Footprint
Table 59. Neuromodulation Devices and Implantable Infusion Pumps Market: Company Product Application Footprint
Table 60. Neuromodulation Devices and Implantable Infusion Pumps New Market Entrants and Barriers to Market Entry
Table 61. Neuromodulation Devices and Implantable Infusion Pumps Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2018-2023) & (Unit)
Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2024-2029) & (Unit)
Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2023) & (Unit)
Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2024-2029) & (Unit)
Table 70. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2023) & (Unit)
Table 75. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2024-2029) & (Unit)
Table 76. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2023) & (Unit)
Table 81. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2024-2029) & (Unit)
Table 82. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2023) & (Unit)
Table 83. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2024-2029) & (Unit)
Table 84. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2023) & (Unit)
Table 85. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2024-2029) & (Unit)
Table 86. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2023) & (Unit)
Table 89. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2024-2029) & (Unit)
Table 90. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2023) & (Unit)
Table 91. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2024-2029) & (Unit)
Table 92. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2023) & (Unit)
Table 93. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2024-2029) & (Unit)
Table 94. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2023) & (Unit)
Table 97. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2024-2029) & (Unit)
Table 98. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2023) & (Unit)
Table 99. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2024-2029) & (Unit)
Table 100. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2018-2023) & (Unit)
Table 101. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2024-2029) & (Unit)
Table 102. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2023) & (Unit)
Table 105. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2024-2029) & (Unit)
Table 106. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2023) & (Unit)
Table 107. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2024-2029) & (Unit)
Table 108. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2018-2023) & (Unit)
Table 109. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Country (2024-2029) & (Unit)
Table 110. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2018-2023) & (Unit)
Table 113. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Type (2024-2029) & (Unit)
Table 114. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2018-2023) & (Unit)
Table 115. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Application (2024-2029) & (Unit)
Table 116. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2018-2023) & (Unit)
Table 117. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity by Region (2024-2029) & (Unit)
Table 118. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Neuromodulation Devices and Implantable Infusion Pumps Raw Material
Table 121. Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps Raw Materials
Table 122. Neuromodulation Devices and Implantable Infusion Pumps Typical Distributors
Table 123. Neuromodulation Devices and Implantable Infusion Pumps Typical Customers
List of Figures
Figure 1. Neuromodulation Devices and Implantable Infusion Pumps Picture
Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Type in 2022
Figure 4. Spinal Cord Stimulation Examples
Figure 5. Deep Brain Stimulation Examples
Figure 6. Sacral Nerve Stimulation Examples
Figure 7. Vagal Nerve Stimulation Examples
Figure 8. Gastric Stimulation Examples
Figure 9. Transcranial Magnetic Stimulation Examples
Figure 10. Transcutaneous Electrical Stimulation Examples
Figure 11. Other Examples
Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Application in 2022
Figure 14. Parkinson's Disease Examples
Figure 15. Epilepsy Examples
Figure 16. Pain Examples
Figure 17. Other Examples
Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity (2018-2029) & (Unit)
Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (2018-2029) & (USD/Unit)
Figure 22. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Manufacturer in 2022
Figure 23. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Manufacturer in 2022
Figure 24. Producer Shipments of Neuromodulation Devices and Implantable Infusion Pumps by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 25. Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Consumption Value) Market Share in 2022
Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2018-2029)
Figure 28. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2018-2029)
Figure 29. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029) & (USD Million)
Figure 30. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029) & (USD Million)
Figure 31. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029) & (USD Million)
Figure 32. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029) & (USD Million)
Figure 33. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value (2018-2029) & (USD Million)
Figure 34. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2018-2029)
Figure 35. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Type (2018-2029)
Figure 36. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Type (2018-2029) & (USD/Unit)
Figure 37. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2018-2029)
Figure 38. Global Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Application (2018-2029)
Figure 39. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Application (2018-2029) & (USD/Unit)
Figure 40. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2018-2029)
Figure 41. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2018-2029)
Figure 42. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2018-2029)
Figure 43. North America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2018-2029)
Figure 44. United States Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Canada Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Mexico Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2018-2029)
Figure 48. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2018-2029)
Figure 49. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2018-2029)
Figure 50. Europe Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2018-2029)
Figure 51. Germany Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. France Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. United Kingdom Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Russia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Italy Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2018-2029)
Figure 57. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2018-2029)
Figure 58. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2018-2029)
Figure 59. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2018-2029)
Figure 60. China Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Japan Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Korea Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. India Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Australia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2018-2029)
Figure 67. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2018-2029)
Figure 68. South America Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Country (2018-2029)
Figure 69. South America Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Country (2018-2029)
Figure 70. Brazil Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Argentina Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Type (2018-2029)
Figure 73. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Application (2018-2029)
Figure 74. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Quantity Market Share by Region (2018-2029)
Figure 75. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value Market Share by Region (2018-2029)
Figure 76. Turkey Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Egypt Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. South Africa Neuromodulation Devices and Implantable Infusion Pumps Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 80. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
Figure 81. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
Figure 82. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Neuromodulation Devices and Implantable Infusion Pumps in 2022
Figure 85. Manufacturing Process Analysis of Neuromodulation Devices and Implantable Infusion Pumps
Figure 86. Neuromodulation Devices and Implantable Infusion Pumps Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
